Monitor for any future conversion to a 13D filing, which would signal activist intent. The stake increase suggests growing conviction but remains passive for now.
ABEO drugs
ABEO drug pipeline →Price Chart
How similar events traded
Executive Summary
Funicular Funds, LP filed an amended Schedule 13G disclosing a 7.5% passive stake in Abeona Therapeutics as of September 30, 2026, up from a prior undisclosed level. The filing confirms passive intent and no activist purpose.
Key Financial Metrics
Key Facts
- Funicular Funds, LP disclosed beneficial ownership of 5,101,883 shares of Abeona Therapeutics common stock.
- The stake represents 7.5% of 68,041,223 voting shares outstanding.
- The filing is an amendment to a Schedule 13G, indicating passive investment intent.
- The reporting persons include Cable Car Capital, LP and Jacob Ma-Weaver as control persons.
- The filing certifies the securities were not acquired to change or influence control of the issuer.
Financial Impact
7.5% passive stake in a $131M market cap company, valued at approximately $9.8M based on market cap.
Risk Factors
- Potential future conversion to activist filing (13D) could signal a change in strategy.
- No material financial data in the filing to assess impact on operations or valuation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0002073679-26-000173 |
| Document: 0002073679-26-000173-index.html | 0002073679-26-000173 |
| Document: 0002073679-26-000173.txt | 0002073679-26-000173 |
Track record
29 reports on ABEO
4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $2.59 Now $2.60 +0.39% settles Nov 18
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $2.30 Now $2.60 +13.04% settles Nov 17
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
- Nov 9, 20267d ago 8-K Bearish 6/10 Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
- Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
- Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
- Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
- Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers